Login / Signup

Fluocinolone Acetonide Implant Injected 1 Month after Dexamethasone Implant for Diabetic Macular Oedema: the ILUVI1MOIS Study.

Nicolas RousseauOlivier LebretonHélène MasseYann MaucourantValentin PipelartManon ClementMarie-Laure Le LezRaoul Kanav KhannaMaxime PepinYannick EudeGuylène Le MeurMichel WeberJean-Baptiste Ducloyer
Published in: Ophthalmology and therapy (2023)
In pseudophakic patients with chronic DME showing good response to DEXi but requiring repeated injections every < 6 months, switching to FAci 1 month after the last DEXi was effective and safe. Further prospective randomized controlled studies are needed to confirm these findings, and to determine the best interval between the last DEXi and the first FAci.
Keyphrases
  • soft tissue
  • type diabetes
  • double blind
  • open label
  • low dose
  • high dose
  • diabetic retinopathy
  • phase iii
  • placebo controlled
  • clinical trial
  • randomized controlled trial
  • ultrasound guided